search
Back to results

Directional Versus Nondirectional DBS for ET

Primary Purpose

Essential Tremor

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Deep brain stimulation of the VIM Thalamic nuclei
Sponsored by
Oregon Health and Science University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Essential Tremor

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A tremor syndrome of bilateral upper limb action tremor with at least 3 years' duration

Exclusion Criteria:

  • Patients who have decided not to receive DBS for control of their medication-refractory essential tremor.
  • Patients with secondary tremor (ie not Essential Tremor), such as side effects from medications, secondary to another identified neurologic disease (eg multiple sclerosis, -----Parkinson's disease, dystonia).
  • Prior history of deep brain stimulation.
  • Prior history of thalamotomy.
  • A history or signs of dystonia, ataxia or parkinsonism.
  • Task specific tremor.
  • Orthostatic tremor.
  • Patients with cardiac pacemakers, defibrillators, or neurostimulators.
  • Patients who require MRI, ECT, rTMS, or diathermy.
  • Subjects with other type of neurological disease or injury.

Sites / Locations

  • Oregon Health & Science UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Directional deep brain stimulation

Nondirectional deep brain stimulation

Arm Description

Deep brain stimulation delivered in a directional manner within an axial plane

Deep brain stimulation delivered in a nondirectional manner within an axial plane

Outcomes

Primary Outcome Measures

Therapeutic window
Range of therapeutic current from clinical improvement to side effect threshold, measured in milliamps, within a range of 0.0 to 5.0 milliamps

Secondary Outcome Measures

Improvement of tremor
Change in The Essential Tremor Rating Scale (TETRAS) combined score. Range = 0 to112. Higher score = worse outcome.
Compare the effects of directional versus nondirectional DBS on self perception of speech
Self Perception of speech: Subjects will rate their "ability to speak" on a VAS (from 0 [normal] to 100 mm [worst]) in each condition.
Compare the effects of directional versus nondirectional DBS on balance and gait
The Activities-specific Balance Confidence (ABC) scale is a 16-item self-report measure in which participants rate their balance confidence on a 0-100 scale (0 = 0 no confidence, 100 = 100 complete confidence).
Compare the effects of directional versus nondirectional DBS on perceptual assessment of voice and speech
Perceptual assessment of voice and speech will be completed with listeners judging a reading sample using a 100mm Visual Analog Scale (VAS).

Full Information

First Posted
February 8, 2021
Last Updated
March 30, 2021
Sponsor
Oregon Health and Science University
search

1. Study Identification

Unique Protocol Identification Number
NCT04828798
Brief Title
Directional Versus Nondirectional DBS for ET
Official Title
Directional Versus Nondirectional Deep Brain Stimulation of the VIM Thalamic Nucleus for Essential Tremor: Assessment of Therapeutic Window, Speech, Gait and Balance
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2021 (Anticipated)
Primary Completion Date
August 8, 2023 (Anticipated)
Study Completion Date
February 8, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oregon Health and Science University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This will be a single center (OHSU) proof of concept trial to demonstrate that directional deep brain stimulation (DBS) creates a larger therapeutic window for the treatment of essential tremor (ET), effectively treats ET, and minimizes effects on speech, gait and balance compared to nondirectional DBS.
Detailed Description
Specific Aims: To compare the therapeutic window (TW) of directional versus nondirectional deep brain stimulation for treatment of tremor. Hypothesis: directional DBS will result in a wider TW than nondirectional DBS. To compare the effects of directional versus nondirectional DBS on speech Hypothesis: Objective and subjective speech impairment will occur to a greater extent in nondirectional DBS versus directional DBS optimized for tremor control. To compare the effects of directional versus nondirectional DBS on balance and gait Hypothesis: Objective and subjective balance and gait impairment will occur to a greater extent in nondirectional DBS versus directional DBS optimized for tremor control. To assess efficacy for tremor of nondirectional and directional DBS in an optimized programming configuration Hypothesis: both directional and nondirectional DBS will significantly improve tremor compared to baseline.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Essential Tremor

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Double-blinded crossover design
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
24 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Directional deep brain stimulation
Arm Type
Active Comparator
Arm Description
Deep brain stimulation delivered in a directional manner within an axial plane
Arm Title
Nondirectional deep brain stimulation
Arm Type
Active Comparator
Arm Description
Deep brain stimulation delivered in a nondirectional manner within an axial plane
Intervention Type
Device
Intervention Name(s)
Deep brain stimulation of the VIM Thalamic nuclei
Intervention Description
Deep brain stimulation of the thalamus, in a directional and nondirectional manner
Primary Outcome Measure Information:
Title
Therapeutic window
Description
Range of therapeutic current from clinical improvement to side effect threshold, measured in milliamps, within a range of 0.0 to 5.0 milliamps
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Improvement of tremor
Description
Change in The Essential Tremor Rating Scale (TETRAS) combined score. Range = 0 to112. Higher score = worse outcome.
Time Frame
3 months
Title
Compare the effects of directional versus nondirectional DBS on self perception of speech
Description
Self Perception of speech: Subjects will rate their "ability to speak" on a VAS (from 0 [normal] to 100 mm [worst]) in each condition.
Time Frame
3 months
Title
Compare the effects of directional versus nondirectional DBS on balance and gait
Description
The Activities-specific Balance Confidence (ABC) scale is a 16-item self-report measure in which participants rate their balance confidence on a 0-100 scale (0 = 0 no confidence, 100 = 100 complete confidence).
Time Frame
3 months
Title
Compare the effects of directional versus nondirectional DBS on perceptual assessment of voice and speech
Description
Perceptual assessment of voice and speech will be completed with listeners judging a reading sample using a 100mm Visual Analog Scale (VAS).
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A tremor syndrome of bilateral upper limb action tremor with at least 3 years' duration Exclusion Criteria: Patients who have decided not to receive DBS for control of their medication-refractory essential tremor. Patients with secondary tremor (ie not Essential Tremor), such as side effects from medications, secondary to another identified neurologic disease (eg multiple sclerosis, -----Parkinson's disease, dystonia). Prior history of deep brain stimulation. Prior history of thalamotomy. A history or signs of dystonia, ataxia or parkinsonism. Task specific tremor. Orthostatic tremor. Patients with cardiac pacemakers, defibrillators, or neurostimulators. Patients who require MRI, ECT, rTMS, or diathermy. Subjects with other type of neurological disease or injury.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zoe Fanning
Phone
503-494-7772
Email
fanningz@ohsu.edu
Facility Information:
Facility Name
Oregon Health & Science University
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zoe Fanning
Phone
503-494-7772
Email
fanningz@ohsu.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Directional Versus Nondirectional DBS for ET

We'll reach out to this number within 24 hrs